Asia Pacific: In Asia Pacific, countries like China, Japan, and South Korea are experiencing a surge in demand for implantable cardioverter defibrillators due to the growing aging population and rising awareness about the benefits of these devices in managing cardiac arrhythmias. Government initiatives to improve healthcare services and increasing healthcare expenditure are further propelling market growth in the region.
Europe: The market for implantable cardioverter defibrillators in Europe, particularly in the United Kingdom, Germany, and France, is witnessing steady growth owing to the high incidence of cardiovascular diseases and the presence of key market players in the region. Technological advancements in medical devices and the focus on early diagnosis and treatment of heart conditions are driving the market expansion in Europe.